Vascular Dynamics has announced it has secured $16.85 million in series B financing.
Vascular Dynamics, headquartered in Mountain View, Calif., provides minimally invasive solutions for the treatment of refractive or resistant hypertension.
This round of financing was led by HBM Healthcare Investments, joined by existing investors Rainbow Medical, the MedFocus Funds and an undisclosed existing investor.
Vascular Dynamics indicated it will use the funding to advance its clinical trial program for the treatment of resistant hypertension in the United States and Europe.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.